Clinical trial
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
NCT01838694 is registered in ClinicalTrials.gov with Invion, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
- Lead sponsor
- Invion, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- August 31, 2015
- Enrollment
- 30 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.